Cerebrolysin in SAH (Subarachnoidal Haemorrhage) - Observational Study

Pomeranian Medical University Szczecin

Status: Completed

Conditions: SAH (Subarachnoid Hemorrhage)

Study type: Observational

Funder types: Other

Identifiers

NCT06429943

SAH/2020/2023

Details and patient eligibility

About

Subarachnoid haemorrhage often affects people in middle age and is associated with high mortality or neurological damage. In recent years, advances in surgical techniques have im-proved the mortality rate. However, there is still need for the research for the optimal possible final effect of treatment. In our study, we've decided to examine the effect of a multimodal approach including Cerebrolysin in the supportive treatment of patients. We've examined the supply of neuroprotective drugs and neuromonitoring.

Enrollment: 47 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age >18 years old, diagnosis of SAH, treatment in ICU conditions

Exclusion criteria

• age <18 years, medical history of allergy to Cerebrolysin, acute renal failure, pregnancy, multi organ trauma, death within 48 hours after admission

Trial design

47 participants in 2 patient groups

A

Description:

Cerebrolysin administration

B

Description:

without Cerebrolysin administration